A detailed history of B. Metzler Seel. Sohn & Co. Ag transactions in Amgen Inc stock. As of the latest transaction made, B. Metzler Seel. Sohn & Co. Ag holds 52,667 shares of AMGN stock, worth $14.7 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
52,667
Previous 50,793 3.69%
Holding current value
$14.7 Million
Previous $15.9 Million 6.93%
% of portfolio
0.17%
Previous 0.17%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$309.38 - $337.38 $579,778 - $632,250
1,874 Added 3.69%
52,667 $17 Million
Q2 2024

Aug 13, 2024

SELL
$262.75 - $319.31 $610,105 - $741,437
-2,322 Reduced 4.37%
50,793 $15.9 Million
Q1 2024

May 15, 2024

BUY
$268.87 - $324.56 $3.1 Million - $3.74 Million
11,535 Added 27.74%
53,115 $15.1 Million
Q4 2023

Feb 13, 2024

BUY
$255.7 - $288.46 $1.59 Million - $1.79 Million
6,205 Added 17.54%
41,580 $12 Million
Q3 2023

Nov 13, 2023

SELL
$218.65 - $271.46 $3.12 Million - $3.88 Million
-14,280 Reduced 28.76%
35,375 $9.51 Million
Q2 2023

Aug 11, 2023

BUY
$214.27 - $253.37 $1.58 Million - $1.87 Million
7,373 Added 17.44%
49,655 $11 Million
Q1 2023

May 10, 2023

SELL
$225.79 - $275.2 $923,481 - $1.13 Million
-4,090 Reduced 8.82%
42,282 $10.2 Million
Q4 2022

Feb 13, 2023

SELL
$229.03 - $291.01 $4.01 Million - $5.1 Million
-17,521 Reduced 27.42%
46,372 $12.2 Million
Q3 2022

Nov 14, 2022

SELL
$224.46 - $253.15 $3.79 Million - $4.27 Million
-16,879 Reduced 20.9%
63,893 $14.4 Million
Q2 2022

Aug 12, 2022

SELL
$230.71 - $256.74 $916,149 - $1.02 Million
-3,971 Reduced 4.69%
80,772 $19.7 Million
Q1 2022

May 10, 2022

SELL
$219.27 - $242.57 $1.37 Million - $1.51 Million
-6,228 Reduced 6.85%
84,743 $20.5 Million
Q4 2021

Feb 11, 2022

BUY
$198.88 - $227.6 $18.1 Million - $20.7 Million
90,971 New
90,971 $20.6 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $149B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track B. Metzler Seel. Sohn & Co. Ag Portfolio

Follow B. Metzler Seel. Sohn & Co. Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of B. Metzler Seel. Sohn & Co. Ag, based on Form 13F filings with the SEC.

News

Stay updated on B. Metzler Seel. Sohn & Co. Ag with notifications on news.